StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Bioxytran's shares outstanding was 114M at Jun 30, 2026. For fiscal 2025 it was 92M, down 33.7% from the year before. Over ten years it grew 24.7% a year on average. The highest annual figure on record is 139M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202592M-33.7%
FY2024Dec 31, 2024139M+3.5%
FY2023Dec 31, 2023134M+18.9%
FY2022Dec 31, 2022113M+6.1%
FY2021Dec 31, 2021106M+13.1%
FY2020Dec 31, 202094M+9.8%
FY2019Dec 31, 201986M+0.6%
FY2018Dec 31, 201885M+115.5%
FY2017Dec 31, 201739M+49.0%
FY2016Dec 31, 201627M+162.9%
FY2015Dec 31, 201510M+126.4%
FY2014Dec 31, 20144M+18.7%
FY2013Dec 31, 20134M+42.2%
FY2012Dec 31, 20123M+87.4%
FY2011Dec 31, 20111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026114M+28.7%
Q1 FY2026Mar 31, 2026112M+26.4%
Q4 FY2025Dec 31, 2025101M+8.2%
Q3 FY2025Sep 30, 202589M-29.6%
Q2 FY2025Jun 30, 202589M-49.7%
Q1 FY2025Mar 31, 202589M-45.6%
Q4 FY2024Dec 31, 202493M-37.0%
Q3 FY2024Sep 30, 2024126M-7.4%
Q2 FY2024Jun 30, 2024177M+37.1%
Q1 FY2024Mar 31, 2024163M+32.4%
Q4 FY2023Dec 31, 2023148M+30.9%
Q3 FY2023Sep 30, 2023136M+17.2%
Q2 FY2023Jun 30, 2023129M+16.2%
Q1 FY2023Mar 31, 2023123M+11.4%
Q4 FY2022Dec 31, 2022113M+2.4%
Q3 FY2022Sep 30, 2022116M+5.9%
Q2 FY2022Jun 30, 2022111M+7.2%
Q1 FY2022Mar 31, 2022111M+10.7%
Q4 FY2021Dec 31, 2021110M+10.7%
Q3 FY2021Sep 30, 2021110M+13.1%
Q2 FY2021Jun 30, 2021103M+6.5%
Q1 FY2021Mar 31, 2021100M+14.7%
Q4 FY2020Dec 31, 202099M+14.2%
Q3 FY2020Sep 30, 202097M+14.0%
Q2 FY2020Jun 30, 202097M+14.0%
Q1 FY2020Mar 31, 202087M+2.5%
Q4 FY2019Dec 31, 201987M+2.2%
Q3 FY2019Sep 30, 201985M+0.1%
Q2 FY2019Jun 30, 201985M+0.0%
Q1 FY2019Mar 31, 201985M0.0%
Q4 FY2018Dec 31, 201885M+9.7%
Q3 FY2018Sep 30, 201885M+167.1%
Q2 FY2018Jun 30, 201885M+167.1%
Q1 FY2018Mar 31, 201885M+248.2%
Q4 FY2017Dec 31, 201778M+158.7%
Q3 FY2017Sep 30, 201732M+21.6%
Q2 FY2017Jun 30, 201732M–
Q1 FY2017Mar 31, 201724M–
Q4 FY2016Dec 31, 201630M–
Q3 FY2016Sep 30, 201626M–

More Bioxytran figures

See a number that looks wrong?